you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals

BSE Live

Aug 12, 16:01
928.00 -87.50 (-8.62%)
Volume
AVERAGE VOLUME
5-Day
26,954
10-Day
17,072
30-Day
8,548
88,612
  • Prev. Close

    1015.50

  • Open Price

    994.00

  • Bid Price (Qty.)

    928.00 (34)

  • Offer Price (Qty.)

    928.00 (4)

NSE Live

Aug 12, 15:59
928.05 -88.25 (-8.68%)
Volume
AVERAGE VOLUME
5-Day
1,079,029
10-Day
645,674
30-Day
394,437
3,897,119
  • Prev. Close

    1016.30

  • Open Price

    988.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    928.05 (360)

Financials

2021 2020 2019 2018 2017
Nine Months Results of Ipca Laboratories (in Rs. Cr.) Dec '21 Dec '20 Dec '19 Dec '18 Dec '17  
Net Sales/Income from operations 4,230.91 4,098.24 3,362.64 2,799.34 2,436.46  
Other Operating Income -- -- -- -- --  
Total Income From Operations 4,230.91 4,098.24 3,362.64 2,799.34 2,436.46  
EXPENDITURE  
Consumption of Raw Materials 1,206.29 1,146.23 1,060.04 831.88 699.66  
Purchase of Traded Goods 191.59 127.75 153.80 123.83 125.22  
Increase/Decrease in Stocks 11.99 7.42 -60.08 -64.93 31.61  
Power & Fuel -- -- -- -- --  
Employees Cost 817.36 711.04 642.91 575.42 544.22  
Depreciation 151.71 139.15 133.31 130.27 131.21  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 939.16 808.86 843.93 814.64 704.00  
P/L Before Other Inc. , Int., Excpt. Items & Tax 912.81 1,157.79 588.73 388.23 200.54  
Other Income 41.92 42.33 51.39 40.01 28.15  
P/L Before Int., Excpt. Items & Tax 954.73 1,200.12 640.12 428.24 228.69  
Interest 4.00 5.83 12.32 12.24 17.57  
P/L Before Exceptional Items & Tax 950.73 1,194.29 627.80 416.00 211.12  
Exceptional Items -- -- -- -- --  
P/L Before Tax 950.73 1,194.29 627.80 416.00 211.12  
Tax 190.20 205.00 103.10 70.56 29.32  
P/L After Tax from Ordinary Activities 760.53 989.29 524.70 345.44 181.80  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 760.53 989.29 524.70 345.44 181.80  
Equity Share Capital 25.37 25.37 25.27 25.27 25.24  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 29.98 78.16 41.53 27.34 14.41  
Diluted EPS 29.98 78.16 41.51 27.34 14.41  
EPS After Extra Ordinary  
Basic EPS. 29.98 78.16 41.53 27.34 14.41  
Diluted EPS. 29.98 78.16 41.51 27.34 14.41  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited